Your browser doesn't support javascript.
loading
Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.
Aung, Tin; Ozaki, Mineo; Lee, Mei Chin; Schlötzer-Schrehardt, Ursula; Thorleifsson, Gudmar; Mizoguchi, Takanori; Igo, Robert P; Haripriya, Aravind; Williams, Susan E; Astakhov, Yury S; Orr, Andrew C; Burdon, Kathryn P; Nakano, Satoko; Mori, Kazuhiko; Abu-Amero, Khaled; Hauser, Michael; Li, Zheng; Prakadeeswari, Gopalakrishnan; Bailey, Jessica N Cooke; Cherecheanu, Alina Popa; Kang, Jae H; Nelson, Sarah; Hayashi, Ken; Manabe, Shin-Ichi; Kazama, Shigeyasu; Zarnowski, Tomasz; Inoue, Kenji; Irkec, Murat; Coca-Prados, Miguel; Sugiyama, Kazuhisa; Järvelä, Irma; Schlottmann, Patricio; Lerner, S Fabian; Lamari, Hasnaa; Nilgün, Yildirim; Bikbov, Mukharram; Park, Ki Ho; Cha, Soon Cheol; Yamashiro, Kenji; Zenteno, Juan C; Jonas, Jost B; Kumar, Rajesh S; Perera, Shamira A; Chan, Anita S Y; Kobakhidze, Nino; George, Ronnie; Vijaya, Lingam; Do, Tan; Edward, Deepak P; de Juan Marcos, Lourdes.
Afiliação
  • Aung T; Singapore Eye Research Institute, Singapore.
  • Ozaki M; Singapore National Eye Center, Singapore.
  • Lee MC; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Schlötzer-Schrehardt U; Ozaki Eye Hospital, Hyuga, Miyazaki, Japan.
  • Thorleifsson G; Department of Ophthalmology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Mizoguchi T; Singapore Eye Research Institute, Singapore.
  • Igo RP; Academic Clinical Program for Ophthalmology and Visual Sciences, Office of Clinical and Academic Faculty Affairs, Duke-NUS Graduate Medical School, Singapore.
  • Haripriya A; Department of Ophthalmology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Williams SE; deCODE Genetics, Reykjavik, Iceland.
  • Astakhov YS; Mizoguchi Eye Hospital, Sasebo, Japan.
  • Orr AC; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
  • Burdon KP; Aravind Eye Hospital, Madurai, India.
  • Nakano S; Division of Ophthalmology, University of the Witwatersrand, Johannesburg, South Africa.
  • Mori K; Department of Ophthalmology, Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia.
  • Abu-Amero K; Department of Ophthalmology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Hauser M; Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Li Z; Department of Ophthalmology, Flinders University, Adelaide, South Australia, Australia.
  • Prakadeeswari G; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
  • Bailey JNC; Department of Ophthalmology, Oita University Faculty of Medicine, Oita, Japan.
  • Cherecheanu AP; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kang JH; Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Nelson S; Department of Ophthalmology, College of Medicine, University of Florida, Jacksonville, Florida, USA.
  • Hayashi K; Singapore Eye Research Institute, Singapore.
  • Manabe SI; Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina, USA.
  • Kazama S; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Zarnowski T; Genome Institute of Singapore, Singapore.
  • Inoue K; Department of Genetics, Aravind Medical Research Foundation, Madurai, India.
  • Irkec M; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
  • Coca-Prados M; 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania.
  • Sugiyama K; Department of Ophthalmology, University Emergency Hospital, Bucharest, Romania.
  • Järvelä I; Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Schlottmann P; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Lerner SF; Hayashi Eye Hospital, Fukuoka, Japan.
  • Lamari H; Hayashi Eye Hospital, Fukuoka, Japan.
  • Nilgün Y; Shinjo Eye Clinic, Miyazaki, Japan.
  • Bikbov M; Department of Diagnostics and Microsurgery of Glaucoma, Medical University, Lublin, Poland.
  • Park KH; Inoue Eye Hospital, Tokyo, Japan.
  • Cha SC; Department of Ophthalmology, Hacettepe University, Faculty of Medicine, Ankara, Turkey.
  • Yamashiro K; Fernández-Vega University Institute and Foundation of Ophthalmological Research, University of Oviedo, Oviedo, Spain.
  • Zenteno JC; Fernández-Vega Ophthalmological Institute, Oviedo, Spain.
  • Jonas JB; Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Kumar RS; Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
  • Perera SA; Department of Medical Genetics, University of Helsinki, Helsinki, Finland.
  • Chan ASY; Organización Médica de Investigación, Buenos Aires, Argentina.
  • Kobakhidze N; Fundación para el Estudio del Glaucoma, Buenos Aires, Argentina.
  • George R; Clinique Spécialisée en Ophtalmologie Mohammedia, Mohammedia, Morocco.
  • Vijaya L; Department of Ophthalmology, Eskisehir Osmangazi University, Meselik, Eskisehir, Turkey.
  • Do T; Ufa Eye Research Institute, Ufa, Russia.
  • Edward DP; Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • de Juan Marcos L; Department of Ophthalmology, Yeungnam University College of Medicine, Daegu, Republic of Korea.
Nat Genet ; 49(7): 993-1004, 2017 07.
Article em En | MEDLINE | ID: mdl-28553957
ABSTRACT
Exfoliation syndrome (XFS) is the most common known risk factor for secondary glaucoma and a major cause of blindness worldwide. Variants in two genes, LOXL1 and CACNA1A, have previously been associated with XFS. To further elucidate the genetic basis of XFS, we collected a global sample of XFS cases to refine the association at LOXL1, which previously showed inconsistent results across populations, and to identify new variants associated with XFS. We identified a rare protective allele at LOXL1 (p.Phe407, odds ratio (OR) = 25, P = 2.9 × 10-14) through deep resequencing of XFS cases and controls from nine countries. A genome-wide association study (GWAS) of XFS cases and controls from 24 countries followed by replication in 18 countries identified seven genome-wide significant loci (P < 5 × 10-8). We identified association signals at 13q12 (POMP), 11q23.3 (TMEM136), 6p21 (AGPAT1), 3p24 (RBMS3) and 5q23 (near SEMA6A). These findings provide biological insights into the pathology of XFS and highlight a potential role for naturally occurring rare LOXL1 variants in disease biology.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mutação Puntual / Síndrome de Exfoliação / Mutação de Sentido Incorreto / Estudo de Associação Genômica Ampla / Aminoácido Oxirredutases Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mutação Puntual / Síndrome de Exfoliação / Mutação de Sentido Incorreto / Estudo de Associação Genômica Ampla / Aminoácido Oxirredutases Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article